teva pharmaceuticals introduces the first generic glp-1 for weight loss launches in U.S. | Teva posted on topic Generic Version of Victoza Now
Description
For example, a recent JAMA study identified rare but serious gastrointestinal risks associated with GLP-1s, while another study revealed that discontinuing GLP-1s early can negate all clinical benefits

They went through years of clinical trials involving thousands of participants, with results reviewed by FDA scientists before approval

Patients with chronic stomach paralysis sometimes require hospitalization, feeding support, intravenous fluids, or surgical intervention to manage ongoing digestive complications

Supporting gut health during GLP-1 medication use Pharmaceutical GLP-1 medications significantly alter gastrointestinal function

Previous serious hypersensitivity reaction: anaphylaxis, angioedema or severe allergic responses to a specific GLP 1 medication mean you shouldnt be re-exposed to that agent
